CRISPR/Cas12J Enzyme With Simplified PAM Recognition for Gene Editing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current CRISPR/Cas systems have limitations such as requiring multiple RNAs, varying sizes, complex PAM sequences, and potential off-target effects, necessitating the development of a more robust system for efficient gene editing.

Innovation Solution

A new CRISPR/Cas system featuring proteins with specific amino acid sequences (SEQ ID NOs: 1-20, 107, 108) and derivatives, capable of binding and cleaving target sequences under guide RNA guidance, with optional conjugation or fusion to enhance functionalities.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If Cas9, C2c1 or CasX is used for gene editing, then gene editing capability is achieved, but multiple guide RNAs are required which increases system complexity

Engineering Contradiction:
Improvegene editing capabilityVSAvoidnumber of guide RNAs required
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent extracts and eliminates the requirement for multiple guide RNAs by designing a simplified CRISPR system that achieves gene editing capability with reduced RNA components, thereby reducing system complexity while maintaining adaptability

Inventive Principle:
Principle #2Taking out (Extraction)

2Productivity

If Cpf1 is used for gene editing, then multiple gene editing is enabled with single guide RNA, but PAM sequence complexity increases

Engineering Contradiction:
Improvemultiple gene editing efficiencyVSAvoidPAM sequence complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent changes the PAM sequence recognition parameters by designing new Cas proteins with simplified PAM requirements, allowing multiple gene editing operations while reducing the complexity of PAM sequence identification and selection

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If C2c1 with 5'-TTN PAM recognition is used, then target site prediction becomes easier, but target site availability is reduced

Engineering Contradiction:
Improvetarget site prediction accuracyVSAvoidtarget site availability
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent creates Cas proteins with universal PAM recognition capabilities that can identify multiple PAM sequence variants, thereby maintaining easy target site prediction while significantly expanding the availability of potential target sites across different genomes

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Productivity

If existing CRISPR/Cas systems are used, then gene editing function is achieved, but off-target effects occur which reduce precision

Engineering Contradiction:
Improvegene editing functionVSAvoidoff-target effect reduction
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent incorporates feedback mechanisms through optimized Cas protein designs that enhance specificity recognition, allowing the system to distinguish more accurately between on-target and off-target sequences, thereby reducing off-target effects while maintaining gene editing functionality

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new system provides efficient and precise gene editing with reduced off-target effects, enabling improved nucleic acid editing capabilities.

Implementation Method 1

uses RNA guidance to specifically bind target sequences on the genome

Methodology Applied
Scientific EffectComplementary base pairing:

Implementation Method 2

cut DNA to produce double-strand breaks

Methodology Applied
Scientific EffectEndonuclease activity: Enzyme

Data Source

PatentUS12435321B2CRISPR/Cas12J enzyme and system
Publication Date: 2025.10.07 CHINA AGRI UNIV
  • US12435321B2 patent drawing
  • US12435321B2 patent drawing
  • US12435321B2 patent drawing

AI summary

Provided are a Cas effector protein, a fusion protein containing said protein, and a nucleic acid molecule coding same. Also provided are a complex and a composition for nucleic acid editing, for example, a complex and a composition for gene or genome editing, containing the Cas effector protein or the fusion protein, or the nucleic acid molecule encoding same. Also provided is a method for nucleic acid editing, for example, a method for gene or genome editing, using the Cas effector protein or the fusion protein.